• 1
    Kärre K. On the immunobiology of natural killer cells. Doctoral thesis, Karolinska Institute, 1981.
  • 2
    Kärre K. Role of target histocompatibility antigens in regulation of natural killer activity: a reevaluation and a hypothesis. In: CallewaertD, HerbermanRB, eds. Mechanisms of Cytotoxicity by NK Cells. San Diego: Academic Press, 1985:8191.
  • 3
    Kiessling R, Klein E, Wigzell H. ‘Natural’ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cell. Specificity and distribution according to genotype. Eur J Immunol 1975;5:1127.
  • 4
    Herbermann RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975;16:21623.
  • 5
    Cudkowicz G, Bennet M. Peculiar immunobiology of bone marrow allografts. I. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med 1971;134:151328.
  • 6
    Kiessling R, Hochmans PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanism for natural killer activity and resistance to hematopoetic grafts. Eur J Immunol 1977;7:65564.
  • 7
    Kiessling R, Petranyi G, Klein G, Wigzell H. Genetic variation of in vitro cytolytic acitivity and in vivo rejection potential of nonimmunized semisengeneic mice against a mouse lymphoma line. Int J Cancer 1975;15:93344.
  • 8
    Snell G. Recognition structures determined by the H-2 complex. Transplant Proc 1976;8:14752.
  • 9
    Rolstad B, Ford WL. The rapid elimination of allogeneic lymphocytes: relationship to established mechanisms of immunity and lymphocyte traffic. Immunol Rev 1983;73:87113.
  • 10
    Stern P, Gidlund M, Örn A, Wigzell H. Natural killer cells mediate lysis of embryonal carcinoma cells lacking MHC. Nature 1980;285:3412.
  • 11
    Trinchieri G, Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus transformed cells. J Exp Med 1978;147:131422.
  • 12
    Scofeld VL, Schlumpberger JM, Weissman IL. Colony specificity in the colonial tunicate Bothryllus and the origins of vertebrate immunity. Am Zool 1982;22:78294.
  • 13
    Hildeman WH. Specific immunorecognition by histocompatibility markers: The original polymorphic system of immunoreactivity characteristic of all multicellular animals. Immunogenetics 1977;5:193202.
  • 14
    Kolb H. On the phylogenetic origin of the immune system – a hypothesis. Dev Comp Immunol 1977;1:193206.
  • 15
    Kärre K. How to recognize a foreign submarine. Immunol Rev 1997;155:59.
  • 16
    Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986;319:6758.
  • 17
    Ljunggren HG, Kärre K. Host resistance directed selectively against H-2 deficient lymphoma, variants – analysis of the mechanism. J Exp Med 1985;162:174553.
  • 18
    Öhlèn C, Bastin J, Ljunggren HG et al. Resistance to H-2 restricted but not to allo H-2 specific graft and CTL responses in lymphoma mutant. J Immunol 1990;145:528.
  • 19
    Ijunggren HG, Cochet M, Pääbo S, Kling G, Kourilsky P, Kärre K. Molecular analysis of H-2 deficient lymphoma variants: distinct defects in H-2 biosynthesis associated with enhanced NK sensitivity. J Immunol 1989;142:29117.
  • 20
    Townsend A, Öhlèn C, Bastin J, Ljunggren HG, Foster L, Kärre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989;340:4438.
  • 21
    Powis SJ, Townsend ARM, Deverson EV, Bastin J, Gutcher GW, Howard JC. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC linked transporter. Nature 1991;3547.
  • 22
    Franksson L, George E, Powis S, Butcher G, Howard J, Kärre K. Tumorigenicity conferred to lymphoma mutant by MHC encoded transporter gene. J Exp Med 1993;177:2016.
  • 23
    Quillet A, Presse FR, Marchiol-Foumigault C et al. Increased resistance to non-MHC restricted cytotoxicity related to HLA-A, B expression; direct demonstration using b2 microglobulin transfected Daudi cells. J Immunol 1988;141:1728.
  • 24
    Storkus WJ, Alexander J, Payne JA, Dawson JR, Cresswell P. Reversal of natural killing susceptibility in target cells expressing transfected class I genes. Proc Natl Acad Sci USA 1988;86:23614.
  • 25
    Taniguchi K, Peterson M, Höglund P, Kiessling R, Klein G, Kärre K. Interferon γ induces lung colonization by intravenously inoculated B 16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. Proc Natl Acad Sci USA 1987;84:34059.
  • 26
    Piontek G, Taniguchi K, Ljunggren HG et al. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression following IFN treatment or in vivo passage. J Immunol 1985;142:29117.
  • 27
    Ljunggren HG, Sturmhöfel K, Wolpert E, Hämmerling G, Kärre K. Transfection of beta-2-microglobulin restores interferon mediated protection from NK cell mediated lysis in YAC-1 lymphoma variants. J Immunol 1990;145:3806.
  • 28
    Ljunggren HG, Öhlèn C, Höglund P, Yamasaki T, Klein G, Kärre K. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts. J Immunol 1989;140:6717.
  • 29
    Eriksson M, Leitz G, Fällman E et al. Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med 1999;190:100512.
  • 30
    Ljunggren HG, Yamasaki T, Collins P, Klein G, Kärre K. Selective acceptance of MHC class I deficient tumor variants in the brain. J Exp Med 1988;167:7307.
  • 31
    Höglund P, Ljunggren HG, Öhlèn C et al. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57Bl mice. J Exp Med 1988;168:146974.
  • 32
    Öhlèn C, Kling G, Höglund P et al. Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 1989;246:6668.
  • 33
    Bix M, Liao NS, Zijstra M, Loring R, Jaenisch R, Raulet D. Rejection of class I MHC deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991;349:32931.
  • 34
    Höglund P, Öhlèn C, Carbone E et al. Recognition of β2 microglobulin negative (β2m-) T cell blasts by natural killer cells from normal but not from β2m-mice: nonresponsiveness controlled by β2m-bone marrow in chimeric mice. Proc Natl Acad Sci USA 1991;88:103326.
  • 35
    Ljunggren HG, Kärre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990;11:23741.
  • 36
    Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly49+ IL-2 activated natural killer cells. Nature 1992;358:6670.
  • 37
    Moretta A, Vitale M, Bottino C et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti p58 antibodies reconstitute lysis of MHC class I protected cells in NK clones displaying different specificities. J Exp Med 1993;178:597605.
  • 38
    Kärre K. MHC gene control of the natural killer system at the level of the target and the host. Semin Cancer Biol 1991;2:295309.
  • 39
    Kärre K. Natural killer cells and the MHC class I pathway of peptide presentation. Semin Immunol 1993;5:12745.
  • 40
    Ciccione E, Moretta A, Moretta L, Höglund P, Öhlèn C, Kärre K. Allorecognition by natural killer cells; nonself or no self? Immunol Today 1991;12:3435.
  • 41
    Brown MG, Dokun AO, Heusel JW et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001;292:9347.